Louisiana State Employees Retirement System Makes New Investment in Shockwave Medical, Inc. (NASDAQ:SWAV)

Louisiana State Employees Retirement System purchased a new stake in shares of Shockwave Medical, Inc. (NASDAQ:SWAV - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,400 shares of the company's stock, valued at approximately $1,982,000.

Several other large investors have also added to or reduced their stakes in the business. Harbour Investments Inc. lifted its position in shares of Shockwave Medical by 3.3% during the 1st quarter. Harbour Investments Inc. now owns 1,300 shares of the company's stock valued at $282,000 after buying an additional 41 shares during the last quarter. Snowden Capital Advisors LLC boosted its holdings in shares of Shockwave Medical by 1.4% during the first quarter. Snowden Capital Advisors LLC now owns 3,035 shares of the company's stock worth $658,000 after purchasing an additional 43 shares during the period. Exchange Traded Concepts LLC grew its position in shares of Shockwave Medical by 11.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 483 shares of the company's stock worth $96,000 after buying an additional 50 shares during the last quarter. Lindbrook Capital LLC raised its holdings in Shockwave Medical by 64.8% in the 3rd quarter. Lindbrook Capital LLC now owns 150 shares of the company's stock worth $30,000 after purchasing an additional 59 shares in the last quarter. Finally, Treasurer of the State of North Carolina grew its holdings in shares of Shockwave Medical by 0.4% during the 3rd quarter. Treasurer of the State of North Carolina now owns 16,390 shares of the company's stock worth $3,263,000 after acquiring an additional 60 shares during the period. Institutional investors own 95.35% of the company's stock.

Shockwave Medical Trading Up 0.0 %

SWAV traded up $0.02 during mid-day trading on Thursday, hitting $327.52. 1,155,585 shares of the stock were exchanged, compared to its average volume of 958,558. The firm's fifty day moving average is $282.20 and its two-hundred day moving average is $227.08. The company has a current ratio of 11.76, a quick ratio of 10.73 and a debt-to-equity ratio of 1.09. Shockwave Medical, Inc. has a 1-year low of $157.00 and a 1-year high of $331.58. The company has a market cap of $12.25 billion, a PE ratio of 84.63, a PEG ratio of 2.43 and a beta of 0.92.

Shockwave Medical (NASDAQ:SWAV - Get Free Report) last issued its quarterly earnings results on Thursday, February 15th. The company reported $1.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.24. Shockwave Medical had a return on equity of 23.97% and a net margin of 20.17%. The firm had revenue of $202.98 million for the quarter, compared to analysts' expectations of $199.43 million. During the same quarter in the previous year, the firm posted $3.71 EPS. The firm's revenue for the quarter was up 41.0% on a year-over-year basis. Equities analysts forecast that Shockwave Medical, Inc. will post 4.94 earnings per share for the current fiscal year.

Insider Transactions at Shockwave Medical

In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of the stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $224.69, for a total value of $898,760.00. Following the completion of the sale, the insider now owns 63,920 shares of the company's stock, valued at $14,362,184.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, VP Trinh Phung sold 1,287 shares of Shockwave Medical stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $232.18, for a total transaction of $298,815.66. Following the sale, the vice president now directly owns 32,933 shares in the company, valued at $7,646,383.94. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Isaac Zacharias sold 4,000 shares of the business's stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $224.69, for a total value of $898,760.00. Following the sale, the insider now directly owns 63,920 shares in the company, valued at approximately $14,362,184.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 93,813 shares of company stock worth $23,762,679. 3.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Morgan Stanley reissued an "equal weight" rating and set a $335.00 price objective (up from $285.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $335.00 price target (up from $270.00) on shares of Shockwave Medical in a report on Monday, April 8th. Wolfe Research reaffirmed a "peer perform" rating on shares of Shockwave Medical in a report on Friday, April 5th. TheStreet upgraded shares of Shockwave Medical from a "c+" rating to a "b" rating in a research report on Thursday, February 15th. Finally, Leerink Partnrs lowered shares of Shockwave Medical from an "outperform" rating to a "market perform" rating in a research note on Friday, April 5th. Ten equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $309.11.

Shockwave Medical Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.